# Efficacy of Rupatadine 5, 10 and 20 mg in Chronic Idiopathic Urticaria

> **NCT00199238** · PHASE2 · TERMINATED · sponsor: **J. Uriach and Company** · enrollment: 248 (actual)

## Conditions studied

- URTICARIA

## Interventions

- **DRUG:** Rupatadine Fumarate

## Key facts

- **NCT ID:** NCT00199238
- **Lead sponsor:** J. Uriach and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-10-28
- **Primary completion:** 2003-11-25
- **Final completion:** 2004-09-27
- **Target enrollment:** 248 (ACTUAL)
- **Last updated:** 2022-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00199238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00199238, "Efficacy of Rupatadine 5, 10 and 20 mg in Chronic Idiopathic Urticaria". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00199238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*